RCE 0.00% 46.0¢ recce pharmaceuticals ltd

Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B, page-9

  1. 583 Posts.
    lightbulb Created with Sketch. 356
    Bpharma, you must get sick of being wrong.
    What is even a "lease photo"? Why would you need to take a photo to report on trial participant numbers? Nothing you say makes sense.

    Here is the actual trial info:
    https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381443

    Six participants were enrolled and commenced trial medication.
    Four participants received topical dosing to wounds as per protocol.
    One participant stopped treatment early.
    One participant switched to conventional antibiotic therapy.

 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
0.000(0.00%)
Mkt cap ! $102.0M
Open High Low Value Volume
46.0¢ 46.5¢ 46.0¢ $19.60K 42.56K

Buyers (Bids)

No. Vol. Price($)
3 41004 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.5¢ 38272 2
View Market Depth
Last trade - 15.56pm 26/07/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.